Edition:
United States

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

3.37USD
22 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.37
Open
$3.49
Day's High
$3.57
Day's Low
$3.35
Volume
58,742
Avg. Vol
106,067
52-wk High
$7.16
52-wk Low
$3.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 4.91 -0.180
Sep '18 21.56 0.186
Jun '18 4.91 -0.138
Mar '18 4.04 -0.191
FY 2017 Dec '17 10.46 -0.367
Sep '17 6.16 -0.210
Jun '17 5.16 -0.258
Mar '17 3.80 -0.344
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 4 7.89 8.88 6.03 14.88
Quarter Ending Sep-19 4 9.29 10.50 6.97 15.42
Year Ending Dec-19 4 34.87 39.40 26.66 67.74
Year Ending Dec-20 4 70.42 90.95 56.71 98.35
Earnings (per share)
Quarter Ending Jun-19 3 -0.07 -0.05 -0.09 -0.05
Quarter Ending Sep-19 3 -0.05 -0.03 -0.06 -0.05
Year Ending Dec-19 3 -0.22 -0.08 -0.29 -0.09
Year Ending Dec-20 4 0.10 0.31 -0.06 0.30
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 62.06 62.40
P/E High - Last 5 Yrs. -- 49.30 56.31
P/E Low - Last 5 Yrs. -- 27.69 28.72
Beta 1.35 0.93 0.93
Price to Sales (TTM) 4.84 7.53 9.62
Price to Book (MRQ) 1.67 3.96 4.53
Price to Tangible Book (MRQ) 3.18 7.02 7.71
Price to Cash Flow (TTM) -- 43.56 43.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.69 1.54
Dividend Yield - 5 Year Avg -- 0.70 0.70
Dividend 5 Year Growth Rate -- 2.09 2.97
Payout Ratio(TTM) -- 21.48 21.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -53.08 7.67 9.20
Sales (TTM) vs TTM 1 Yr. Ago 38.47 4.62 8.35
Sales - 5 Yr. Growth Rate 210.35 9.81 11.12
EPS (MRQ) vs Qtr. 1 Yr. Ago 51.02 137.79 110.61
EPS (TTM) vs TTM 1 Yr. Ago 72.66 -- --
EPS - 5 Yr. Growth Rate -- 5.17 6.92
Capital Spending - 5 Yr. Growth Rate -- 6.57 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 8.40 2.67 2.66
Current Ratio (MRQ) 10.46 3.69 3.63
LT Debt to Equity (MRQ) 0.00 12.46 13.26
Total Debt to Equity (MRQ) 0.00 15.13 16.97
Interest Coverage (TTM) -12.21 30.53 27.27

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 69.93 51.66 50.31
Gross Margin - 5 Yr. Avg. 67.37 49.84 50.77
EBITD Margin (TTM) -30.77 -- --
EBITD - 5 Yr. Avg -150.97 17.18 15.78
Operating Margin (TTM) -33.57 3.40 -2.09
Operating Margin - 5 Yr. Avg. -216.15 13.49 11.11
Pre-Tax Margin (TTM) -41.57 2.52 -2.92
Pre-Tax Margin - 5 Yr. Avg. -219.66 20.30 16.76
Net Profit Margin (TTM) -41.57 -1.27 -6.86
Net Profit Margin - 5 Yr. Avg. -216.55 15.16 11.72
Effective Tax Rate (TTM) -- 22.76 22.86
Effective Tax Rate - 5 Yr. Avg. -- 23.62 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 426,651 905,177,527 773,166,387
Net Income/Employee (TTM) -177,374 104,261,468 89,056,262
Receivable Turnover (TTM) 15.36 5.42 5.22
Inventory Turnover (TTM) 0.85 2.62 3.65
Asset Turnover (TTM) 0.29 0.84 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -12.19 9.94 9.54
Return on Assets - 5 Yr. Avg. -29.12 11.04 10.49
Return on Investment (TTM) -14.68 12.17 11.78
Return on Investment - 5 Yr. Avg. -33.42 14.08 13.39
Return on Equity (TTM) -16.27 13.11 12.61
Return on Equity - 5 Yr. Avg. -40.05 15.31 14.86
  1 Year 3 Year 5 Year
Sales % 38.47 273.80 210.35
EPS (TTM) % 73.08 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aratana Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.62 -10.19 28 20
13 Week -15.46 -23.29 23 9
26 Week -35.19 -38.23 16 41
52 Week -32.82 -37.36 31 47
YTD -42.90 -50.73 4 17
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 71.92%
# of Holders: 146
Total Shares Held: 35,220,932
3 Mo. Net Change: 1,600,461
# New Positions: 2
# Closed Positions: 7
# Increased Positions: 7
# Reduced Positions: 15
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.